IVIG for Infection Prevention After CAR-T-Cell Therapy

Clinical trial NCT05952804 · RECRUITING

Trial details

NCT number: NCT05952804
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2024-06-10
Primary completion: 2028-07-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.